ML-347, also known as LDN193719, is a potent and selective bone morphogenetic protein receptor (BMP) inhibitor that inhibits ALK1 and ALK2 with IC50 values of 46 and 32 nM, respectively. ML347 shows >300-fold selectivity for ALK2.
CAS Number: 1062368-49-3
Molecular Weight: 352.39
Chemical Name: 5-(6-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline
Appearance: Solid Power.
Purity: ≥98% (or refer to the Certificate of Analysis)
Solubility: Soluble in DMSO, not in water
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥12 months if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined.
HS Tariff Code: 382200
- Engers DW, Frist AY, Lindsley CW, Hong CH, Hopkins CR. Development of a potentand ALK2 selective bone morphogenetic protein receptor (BMP) inhibitor. 2013 Apr12 [updated 2014 Sep 18]. Probe Reports from the NIH Molecular Libraries Program[Internet]. Bethesda (MD): National Center for Biotechnology Information (US);2010-. Available from http://www.ncbi.nlm.nih.gov/books/NBK259191/PubMed PMID: 25506972.
- Engers DW, Frist AY, Lindsley CW, Hong CC, Hopkins CR. Synthesis andstructure-activity relationships of a novel and selective bone morphogeneticprotein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidinescaffold of dorsomorphin: the discovery of ML347 as an ALK2 versus ALK3 selectiveMLPCN probe. Bioorg Med Chem Lett. 2013 Jun 1;23(11):3248-52. doi:10.1016/j.bmcl.2013.03.113. Epub 2013 Apr 11. PubMed PMID: 23639540; PubMedCentral PMCID: PMC3677712.
Products are for research use only. Not for human use.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.